Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
A Phase I open label study to asses the safety and tolerability of ZD6474 in combination with
Irinotecan, 5-Fluorouracil and Leucovorin (FOLFIRI) as first or second line therapy in
patients with metastatic colorectal adenocarcinoma.